RELMADA THERAPEUTICS, INC. Shareholders' Equity
RELMADA THERAPEUTICS, INC. (RLMD) had Shareholders' Equity of $206.56 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $206.56M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $218.73M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $86.51M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $9.47M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $206.56M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $218.73M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $86.51M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $9.47M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $15.95M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $22.44M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $35.52M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $47.63M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $61.49M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $72.05M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $85.36M 10-K · filed 2026-03-19 | |
| 2023-09-30 | $100.73M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $111.34M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $125.47M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $140.44M 10-K · filed 2025-03-27 | |
| 2022-09-30 | $166.34M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $196.85M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $210.40M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $208.26M 10-K · filed 2024-03-19 | |
| 2021-09-30 | $72.69M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $96.85M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $91.15M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $105.58M 10-K · filed 2023-03-23 | |
| 2020-09-30 | $122.21M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $132.23M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $113.16M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $115.68M 10-K · filed 2022-03-25 | |
| 2019-09-30 | $5.98M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $7.61M 10-K · filed 2021-03-24 | |
| 2019-03-31 | $473.90K 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $1.43M 10-Q · filed 2020-11-12 | |
| 2018-09-30 | -$8.68M 10-Q · filed 2019-11-13 | -$8.74M 10-Q · filed 2018-11-13 |
| 2018-06-30 | -$5.51M 10-K · filed 2021-03-24 | |
| 2018-03-31 | -$2.32M 10-Q · filed 2019-05-15 | |
| 2017-12-31 | $721.16K 10-Q · filed 2019-05-15 | |
| 2017-09-30 | $1.46M 10-Q · filed 2019-05-15 | |
| 2017-06-30 | $1.46M 10-KT · filed 2020-03-26 | |
| 2017-03-31 | $2.80M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $4.67M 10-Q · filed 2017-02-10 | |
| 2016-09-30 | $5.57M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $7.04M 10-K · filed 2018-09-28 | |
| 2016-03-31 | $10.20M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $11.76M 10-Q · filed 2016-02-05 | |
| 2015-09-30 | $13.84M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $8.81M 10-K · filed 2017-09-28 | |
| 2015-03-31 | $2.49M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $4.59M 10-Q · filed 2015-02-13 | |
| 2014-09-30 | -$20.72M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | -$1.11M 10-K · filed 2016-09-09 | |
| 2014-03-31 | -$11.38M 8-K · filed 2014-05-27 | |
| 2014-02-28 | -$31.16K 10-Q · filed 2014-04-15 | |
| 2013-12-31 | -$17.95M 10-K · filed 2015-09-11 | |
| 2013-11-30 | -$28.03K 10-Q · filed 2014-01-13 | |
| 2013-08-31 | -$13.66K 10-Q · filed 2014-04-15 | |
| 2013-05-31 | -$21.29K 10-Q · filed 2013-07-12 | |
| 2013-02-28 | -$1.81K 10-Q · filed 2013-05-03 | |
| 2012-12-31 | -$3.71M 10-K · filed 2015-09-11 | |
| 2012-08-31 | $11.36K 10-K · filed 2013-12-16 | |
| 2011-12-31 | -$2.84M 10-KT · filed 2014-09-09 | |
| 2011-08-31 | $9.91K 10-K · filed 2013-12-16 | |
| 2010-12-31 | -$2.11M 8-K · filed 2014-05-27 | |
| 2009-12-31 | -$1.31M 8-K · filed 2014-05-27 | |
| 2008-12-31 | -$187.93K 8-K · filed 2014-05-27 | |
| 2007-12-31 | $1.58M 8-K · filed 2014-05-27 | |
| 2006-12-31 | -$2.85M 8-K · filed 2014-05-27 | |
| 2005-12-31 | -$1.82M 8-K · filed 2014-05-27 | |
| 2004-12-31 | -$805.73K 8-K · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |